COCHLEAR LTD ADR 1/2/O.N. (OC50) - Total Liabilities
Based on the latest financial reports, COCHLEAR LTD ADR 1/2/O.N. (OC50) has total liabilities worth €874.70 Million EUR (≈ $1.02 Billion USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore OC50 net asset momentum to track the company's year-over-year net asset growth rate.
COCHLEAR LTD ADR 1/2/O.N. - Total Liabilities Trend (2022–2025)
This chart illustrates how COCHLEAR LTD ADR 1/2/O.N.'s total liabilities have evolved over time, based on quarterly financial data.
COCHLEAR LTD ADR 1/2/O.N. Competitors by Total Liabilities
The table below lists competitors of COCHLEAR LTD ADR 1/2/O.N. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Perseus Mining Limited
F:P4Q
|
Germany | €270.94 Million |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥8.08 Billion |
|
China Nuclear Engineering Co
SHG:601611
|
China | CN¥191.01 Billion |
|
Trina Solar Co Ltd
SHG:688599
|
China | CN¥90.54 Billion |
|
Bumrungrad Hospital PCL
BK:BH
|
Thailand | ฿5.29 Billion |
|
Spirit Aerosystems Holdings Inc
NYSE:SPR
|
USA | $10.62 Billion |
|
Blue Owl Technology Finance Corp.
NYSE:OTF
|
USA | $5.35 Billion |
|
Turkcell Iletisim Hizmetleri A.S
F:TUL1
|
Germany | €248.39 Billion |
Liability Composition Analysis (2022–2025)
This chart breaks down COCHLEAR LTD ADR 1/2/O.N.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of COCHLEAR LTD ADR 1/2/O.N..
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.35 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.45 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.31 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how COCHLEAR LTD ADR 1/2/O.N.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for COCHLEAR LTD ADR 1/2/O.N. (2022–2025)
The table below shows the annual total liabilities of COCHLEAR LTD ADR 1/2/O.N. from 2022 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | €874.70 Million ≈ $1.02 Billion |
-3.31% |
| 2024-06-30 | €904.60 Million ≈ $1.06 Billion |
+10.33% |
| 2023-06-30 | €819.90 Million ≈ $958.55 Million |
+5.20% |
| 2022-06-30 | €779.40 Million ≈ $911.20 Million |
-- |
About COCHLEAR LTD ADR 1/2/O.N.
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products. It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal hearing solution, and Nucleus implants; cochlear Baha systems comprising Baha 6 max sound processor… Read more